Literature DB >> 18977234

Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients.

Ewelina Synowiec1, Joanna Stefanska, Zbigniew Morawiec, Janusz Blasiak, Katarzyna Wozniak.   

Abstract

The cell's susceptibility to DNA damage and its ability to repair this damage are important for cancer induction, promotion and progression. In the present work we determined the level of basal (total endogenous) and endogenous oxidative DNA damage as well as polymorphism of the DNA repair genes: RAD51 (135 G/C), XRCC3 (Thr241Met), OGG1 (Ser326Cys) and XPD (Lys751Gln) in peripheral blood lymphocytes of 41 breast cancer patients and 48 healthy individuals. DNA damage was evaluated by alkaline comet assay with DNA repair enzymes: Endo III and Fpg, preferentially recognizing oxidized DNA bases. The genotypes of the polymorphisms were determined by restriction fragment length polymorphism PCR. We observed a strong association between breast cancer occurrence and the genotypes C/C of the RAD51-135G/C polymorphism, Ser/Ser of the OGG1-Ser326Cys and Lys/Gln of the XPD-Lys751Gln, whereas the genotypes G/C of the RAD51-135G/C and Lys/Lys of the XPD-Lys751Gln exerted a protective effect against breast cancer. We also found that individuals with the G/C genotype of the RAD51-135G/C polymorphism and with the Lys/Lys genotype of the XPD-Lys751Gln polymorphism displayed a lower extent of basal and oxidative DNA damage. A strong association between higher level of oxidative DNA damage and the Lys/Gln genotype of the latter polymorphism was found. We also correlated genotypes with clinical characteristics of breast cancer patients. We observed a strong association between the G/C genotype of the RAD51-135 G/C polymorphism and the expression of the progesterone receptor and between both alleles of the OGG1-Ser326Cys polymorphism and lymph node metastasis. Our results suggest that the polymorphism of the RAD51, OGG1 and XPD genes may be linked with breast cancer by the modulation of the cellular response to oxidative stress and these polymorphisms may be considered as markers in breast cancer along with the genetic or/and environmental indicators of oxidative stress.

Entities:  

Mesh:

Year:  2008        PMID: 18977234     DOI: 10.1016/j.mrfmmm.2008.09.014

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  35 in total

1.  XPD Asp312Asn polymorphism is a risk factor for prostate cancer.

Authors:  Shao-Guang Liao; Lu Liu; Ying Wang; Ying-Yi Zhang; Ya-Jie Wang
Journal:  J Cancer Res Clin Oncol       Date:  2012-05-29       Impact factor: 4.553

2.  Genetic 135G/C polymorphism of RAD51 gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls.

Authors:  Bei-Bei Zhang; Dao-Gang Wang; Chao Xuan; Gui-Li Sun; Kai-Feng Deng
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

3.  Association between RAD51 polymorphism and breast cancer susceptibility: a meta analysis.

Authors:  Wei Li; Ke-Jia Liu; Jing-Song Song; Rui Song; Zi-Liang Liu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 4.  A systematic review and meta-analysis of the association between OGG1 Ser326Cys polymorphism and cancers.

Authors:  Ping-Ting Zhou; Bo Li; Jun Ji; Meng-Meng Wang; Chun-Fang Gao
Journal:  Med Oncol       Date:  2015-01-15       Impact factor: 3.064

5.  The hOGG1 Ser326Cys Gene Polymorphism and Breast Cancer Risk in Saudi Population.

Authors:  Mohammed Alanazi; Akbar Ali Khan Pathan; Jilani P Shaik; Abdullah Alhadheq; Zahid Khan; Wajahatullah Khan; Abdulrahman Al Naeem; Narasimha Reddy Parine
Journal:  Pathol Oncol Res       Date:  2016-11-07       Impact factor: 3.201

6.  TaqI polymorphism of VDR gene contributes to breast cancer risk.

Authors:  Hua Wang; Wenjian Wang; Dongjie Yang; Shenming Wang
Journal:  Tumour Biol       Date:  2013-08-01

7.  Reduced expression of DNA repair genes (XRCC1, XPD, and OGG1) in squamous cell carcinoma of head and neck in North India.

Authors:  Anil Kumar; Mohan Chand Pant; Hirdya Shanker Singh; Shashi Khandelwal
Journal:  Tumour Biol       Date:  2011-11-15

8.  Role of XRCC3, XRCC1 and XPD single-nucleotide polymorphisms in survival outcomes following adjuvant chemotherapy in early stage breast cancer patients.

Authors:  E Castro; D Olmos; A Garcia; J J Cruz; R González-Sarmiento
Journal:  Clin Transl Oncol       Date:  2013-06-06       Impact factor: 3.405

9.  Analysis of DNA Repair Genes Polymorphisms in Breast Cancer.

Authors:  Hanna Romanowicz; Łukasz Pyziak; Filip Jabłoński; Magdalena Bryś; Ewa Forma; Beata Smolarz
Journal:  Pathol Oncol Res       Date:  2016-08-29       Impact factor: 3.201

10.  Basal levels of DNA damage detected by micronuclei and comet assays in untreated breast cancer patients and healthy women.

Authors:  Raquel A Santos; Ana Cláudia Teixeira; Monica B Mayorano; Hélio H A Carrara; Jurandyr M Andrade; Catarina S Takahashi
Journal:  Clin Exp Med       Date:  2009-11-10       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.